Free radicals as mediators of tissue injury and disease

Critical Reviews in Toxicology

Volumn 23, Issue 1, 1993, Pages 21-48

  Kehrer, James P ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Atherosclerosis; Bipyridilium compounds; Cancer; Free radicals; Inflammation; Metal chelates; Nitro compounds; Oxygen radicals; Oxygen toxicity; Quinines; Reperfusion injury; Rheumatoid arthritis

Indexed keywords

CHELATING AGENT; FREE RADICAL; NITRO DERIVATIVE; OXYGEN RADICAL; QUINONE DERIVATIVE;

ATHEROSCLEROSIS; CANCER; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; RHEUMATOID ARTHRITIS; TISSUE INJURY;

ANIMAL; ARTERIOSCLEROSIS; ARTHRITIS, RHEUMATOID; DISEASE; FREE RADICALS; HUMAN; INFLAMMATION; NEOPLASMS; REPERFUSION INJURY; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027408080     PISSN: 10408444     EISSN: None     Source Type: Journal    
DOI: 10.3109/10408449309104073     Document Type: Article

References (161)

1. Oxidants and human disease: some new concepts
2. Oxidative stress: introductory remarks
3. Oxidative stress: introduction
4. Oxygen
5. Oxygen toxicity and reactive oxygen metabolites in mammals
6. Singlet oxygen: a potential culprit in myocardial injury?
7. Singlet oxygen production by biological systems
8. Repair systems in oxidative stress
9. Biochemistry of oxidative stress
10. Free radical tissue damage: protective role of antioxidant nutrients
11. Free radicals and antioxidant protection: mechanisms and significance in toxicology and disease
12. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent
13. Leukocyte oxygen activation and microbicidal oxidative toxins
14. Oxygen-centered free radicals as mediators of inflammation
15. Free radicals and inflammation: superoxide-dependent activation of a neutrophil chemotactic factor in plasma
16. The cellular production of hydrogen peroxide
17. Superoxide radicals as precursors of mitochondrial hydrogen peroxide
18. Mitochondrial production of superoxide anions and its relationship to the antimycin insensitive respiration
19. Respiratory chain linked H302 production in pigeon heart mitochondria
20. Flavin and pyridine nucleotide oxidation-reduction changes in perfused rat liver
21. Do mitochondria produce oxygen radicals, in vivo?
22. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria
23. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen
24. Mitochondrial hydrogen peroxide generation and activities of glutathione peroxidase and superoxide dis-mutase following global ischemia
25. Production of reactive oxygen by mitochondria from normoxic and hypoxic rat heart tissue
26. Mitochondrial hydrogen peroxide generation by NADH-oxidase activity following regional myocardial ischemia in the dog
27. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria
28. Role of ubiquinone in the mitochondrial generation of hydrogen peroxide
29. The participation of coenzyme Q in free radical production and antioxidation
30. The involvement of free radicals in the mechanisms of monooxygenases
31. The enzymes of detoxication
32. Qualitative aspects of the production of superoxide anion radical by milk xanthine oxidase
33. Characterization of free radical generation by xanthine oxidase. Evidence for hydroxyl radical generation
34. Concepts related to the study of reactive oxygen and cardiac reperfusion injury
35. Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
36. Current status review: free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis
37. Active oxygen in neuromuscular disorders
38. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury
39. Protein damage and degradation by oxygen radicals. I. General aspects
40. Intracellular proteolytic systems may function as secondary antioxidant defenses: an hypothesis
41. Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences
42. Protein oxidation and aging
43. + depletion and cytotoxicity in isolated hepatocytes
44. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase
45. Mechanisms of endothelial cell ATP depletion after oxidant injury
46. Inflammation and oxidative stress in carcinogenesis
47. Regulation of antioxidant enzymes
48. Acetaminophen structure-toxicity studies: in vivo covalent binding of a nonhepatotoxic analog, 3-hydroxyacetanilide
49. Oxidation of reactive sulfhydryl groups of sarcoplasmic reticulum ATPase
50. 2+-ATPase
51. The relationship between cellular ion deregulation and acute and chronic toxicity
52. The role of cell calcium in current approaches to toxicology
53. The role of calcium in lethal cell injury
54. Calcium ions and oxidative cell injury
55. Review of the current status of calcium and thiols in cellular injury
56. Free radical formation by antitumor qui-nones
57. Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free-radical induced toxicity and glutathione-dependent protection
58. Activation of pharmacologic agents to radical intermediates. Implications for the role of free radicals in drug action and toxicity
59. Overview of enzyme systems involved in bioreduction of drugs and in redox cycling
60. Qui-none stimulated superoxide formation by subcellular fractions, isolated hepatocytes and other cells
61. Biochemical mechanisms of oxidative liver cell injury
62. Quinone chemistry and toxicity
63. Release of iron from ferritin and its role on oxygen radicals toxicities
64. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts
65. The metabolic activation of nitroheterocyclic therapeutic agents
66. The mechanism of paraquat toxicity in the lung
67. The influence of hyperoxia on the acute toxicity of paraquat and diquat
68. Pathobiochemical mechanisms of hepatocellular damage following lipid peroxidation
69. Three models of free radical-induced ceil injury
70. Oxygen, ischemia and inflammation
71. Biological effects of the superoxide radical
72. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides
73. Oxidants, inflammation, and anti-inflammatory drugs
74. Iron as a biological pro-oxidant
75. The determination of dehydroascorbic acid and ascorbic acid in the serum and synovial fluid of patients with rheumatoid arthritis (RA)
76. Oxidative cross-linking of immune complexes by human polymorphonuclear leukocytes
77. Free radicals and inflammation. Protection of synovial fluid by superoxide dismutase
78. Free radicals and anti-inflammatory drugs
79. Superoxide dismutase and cat-alase as therapeutic agents for human diseases. A critical review
80. Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils
81. An-tiarthritic activity of the newly developed neutrophil oxidative burst antagonist apocynin
82. Binding site on macrophages that mediates the uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
83. Role of oxidatively modified LDL in atherosclerosis
84. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
85. Antioxidants in the prevention of human atherosclerosis Summary of the proceedings of a National Heart, Lung, and Blood Institute workshop: September 5–6, 1991 Bethesda, Maryland
86. Lipid peroxides as a cause of vascular diseases
87. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by the receptor for acetylated low density lipoprotein
88. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells
89. Uptake of chemically modified low density lipoproteins in vivo is mediated by specific endothelial cells
90. Lipoprotein oxidation and lipopro-tein-induced cytotoxicity
91. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic
92. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes
93. Role of β-carotene in the oxidative modification of low density lipoproteins
94. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids
95. α-Tocopherol consumption during low-density lipoprotein oxidation
96. Antiatherogenic effect of probucol unrelated to its hypochlesterolemic effect: evidence that antioxidants in vivo can selectively inhibit LDL degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit
97. Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Watanabe rabbits with use of a probucol analogue (MDL 29,311) that does not lower serum cholesterol
98. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine
99. Role of vitamin E in preventing the oxidation of low-density lipoprotein
100. Chemcial carcinogenesis. A biologic perspective
101. Free radical metabolites of chemical carcinogens
102. Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion
103. Identification and assessment of tumor-promoting and cocarcinogenic agents: state-of-the-art in vitro methods
104. Tumor promotion in skin: are active oxygen species involved?
105. Role of oxygen free radicals in carcinogenesis and brain ischemia
106. Free radicals and carcinogenesis
107. Role of free radicals in tumor promotion and progression
108. Prooxidant states and tumor promotion
109. Diacylglycerol, 1-oleoyl-2-acetyl-glycerol, stimulates superoxide-generation from human neutrophils
110. 12- O-Tetradecanoyl-phorbol-13-acetate-dependent induction of xanthine dehydrogenase and conversion to xanthine oxidase in murine epidermis
111. Conversion of xanthine dehydrogenase to oxidase in ischemic rat tissues
112. Mechanisms of oxidant carcinogenesis
113. Active oxygen acts as a promoter of transformation in mouse embryo C3H/10T1/2/C18 fibroblasts
114. Phagocytes as carcinogens: malignant transformation produced by human neutrophils
115. Cell division in normal and transformed cells: the possible role of superoxide and hydrogen peroxide
116. Diminution of mouse epidermal superoxide dismutase and catalase activities by tumor promoters
117. Inhibition of the effects of 12- O-tetradecanoylphorbol-13-acetate on mouse epidermal glutathione peroxidase and ornithine decarboxylase activities by glutathione level-raising agents and selenium-containing compounds
118. Decreased ratio of reduced/oxidized glutathione in mouse epidermal cells treated with tumor promoters
119. Free-radical processes in multistage carcinogenesis
120. Relationship between the metabolism of bu-tylated hydroxytoluene (BHT) and lung tumor promotion in mice
121. An overview of the relationship between oxidative stress and chemical carcinogenesis
122. Direct detection of radical production in the ischaemic and reperfused myocardium: current status
123. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues
124. Problems associated with reperfusion of ischemic myocardium
125. Models and markers used to study cardiac reperfusion injury
126. Tetrazolium artifactually indicates superoxide dismutase-induced salvage in reperfused rabbit heart
127. Superoxide dismutase therapy for myocardial ischemia
128. Mechanism of myocardial “stunning
129. Oxygen-derived free radicals and myocardial reperfusion injury: an overview
130. Reperfusion-induced arrhythmias: do free radicals play a critical role?
131. Lack of significant effects of superoxide dismutase and catalase on development of reperfusion arrhythmias
132. Molecular mechanisms in “stunned” myocardium
133. Protection of the myocardium against postischemic reperfusion damage
134. Role of oxygen radicals in myocardial reperfusion injury: experimental and clinical evidence
135. Free radicals in ischemic and reperfusion myocardial injury: is this the time for clinical trials
136. Importance of free radicals generated by endothelial and myocardial cells in ischemia and reperfusion
137. The role of neutrophils and free radicals in the ischemic-reperfused heart: why the confusion and controversy?
138. The protection of the ischemic myocardium: surgical success v. clinical failure
139. Free radicals in aging
140. Protein, lipid and DNA repair systems in oxidative stress: the free-radical theory of aging revisited
141. Normobaric pulmonary oxygen toxicity
142. Hyperoxia increases oxygen radical production in rat lung homogenates
143. The relation of free radical production to hyperoxia
144. Oxygen tolerance in neonatal rats: role of subcellular superoxide generation
145. Reduction of the edema of acute hyperoxic lung injury by granulocyte depletion
146. Effects of hyperoxia on alveolar permeability of neutropenic rabbits
147. Oxygen toxicity in neonatal and adult animals
148. Protection from oxygen toxicity with endotoxin: role of the endogenous antioxidant enzymes of the lung
149. Transgenic mice with expression of elevated levels of copper-zinc superoxide dismutase in the lungs are resistant to pulmonary oxygen toxicity
150. Developmental aspects of experimental pulmonary oxygen toxicity
151. Endotoxin protection of rats from pulmonary oxygen toxicity: possible cytokine involvement
152. Protection against hyperoxia by serum from endotoxin treated rats: absence of superoxide dismutase induction
153. Erythrocyte insufflation-induced protection against oxygen toxicity: role of cytokines
154. Tumor necrosis factor induced oxidative stress in isolated mouse hepatocytes
155. Pulmonary metabolism of reactive oxygen species
156. 2 toxicity in the newborn rat
157. Polyethylene glycol-attached antioxidant enzymes decrease pulmonary oxygen toxicity in rats
158. Protective role of sulfhydryl reagents in oxidant lung injury
159. Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects